Cite
Haselbeck AH, Tadesse BT, Park J, et al. Evaluation of Typhoid Conjugate Vaccine Effectiveness in Ghana (TyVEGHA) Using a Cluster-Randomized Controlled Phase IV Trial: Trial Design and Population Baseline Characteristics. Vaccines (Basel). 2021;9(3)doi: 10.3390/vaccines9030281.
Haselbeck, A. H., Tadesse, B. T., Park, J., Gibani, M. M., Espinoza, L. M. C., Abreu, A., Van Rensburg, C., Owusu-Ansah, M., Twuamsi-Ankrah, S., Owusu, M., Aguna, I., Picot, V., Jeon, H., Higginson, E., Park, S., Mojares, Z. R., Im, J., Carey, M. E., Khanam, F., Tonks, S., Dougan, G., Kim, D., Sugimoto, J., Mogasale, V., Neuzil, K. M., Qadri, F., Adu-Sarkodie, Y., Owusu-Dabo, E., Clemens, J., & Marks, F. (2021). Evaluation of Typhoid Conjugate Vaccine Effectiveness in Ghana (TyVEGHA) Using a Cluster-Randomized Controlled Phase IV Trial: Trial Design and Population Baseline Characteristics. Vaccines, 9(3), . https://doi.org/10.3390/vaccines9030281
Haselbeck, Andrea Haekyung, et al. "Evaluation of Typhoid Conjugate Vaccine Effectiveness in Ghana (TyVEGHA) Using a Cluster-Randomized Controlled Phase IV Trial: Trial Design and Population Baseline Characteristics." Vaccines vol. 9,3 (2021). doi: https://doi.org/10.3390/vaccines9030281
Haselbeck AH, Tadesse BT, Park J, Gibani MM, Espinoza LMC, Abreu A, Van Rensburg C, Owusu-Ansah M, Twuamsi-Ankrah S, Owusu M, Aguna I, Picot V, Jeon H, Higginson E, Park S, Mojares ZR, Im J, Carey ME, Khanam F, Tonks S, Dougan G, Kim D, Sugimoto J, Mogasale V, Neuzil KM, Qadri F, Adu-Sarkodie Y, Owusu-Dabo E, Clemens J, Marks F. Evaluation of Typhoid Conjugate Vaccine Effectiveness in Ghana (TyVEGHA) Using a Cluster-Randomized Controlled Phase IV Trial: Trial Design and Population Baseline Characteristics. Vaccines (Basel). 2021 Mar 19;9(3). doi: 10.3390/vaccines9030281. PMID: 33808924; PMCID: PMC8003794.
Copy
Download .nbib